Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cefa-Cilinas Biotics is an Indian pharmaceutical company specializing in the manufacture and export of high-quality antibiotic formulations. The company's core expertise lies in the production of Cephalosporins and Penicillins, which are marketed in various dosage forms including tablets, capsules, and dry syrups. Operating from a WHO-GMP certified facility in Hubli, Karnataka, the firm provides contract manufacturing services to several leading pharmaceutical brands. Their product portfolio features essential anti-infectives such as Cefixime, Amoxicillin, and Cefpodoxime Proxetil. Cefa-Cilinas Biotics serves a global market, exporting its products to regions across Southeast Asia, Africa, and the CIS. The company is committed to maintaining international quality standards to ensure the efficacy and safety of its life-saving medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cefa-Cilinas Biotics.